4//SEC Filing
LAWLIS V BRYAN 4
Accession 0001567619-22-008633
CIK 0001048477other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 8:22 PM ET
Size
8.2 KB
Accession
0001567619-22-008633
Insider Transaction Report
Form 4
LAWLIS V BRYAN
Director
Transactions
- Exercise/Conversion
Common Stock
2022-04-14$37.46/sh+4,250$159,205→ 28,220 total - Exercise/Conversion
Stock Option (Right to buy Common Stock)
2022-04-14−4,250→ 0 totalExercise: $37.46From: 2012-11-08Exp: 2022-05-07→ Common Stock (4,250 underlying) - Sale
Common Stock
2022-04-14$83.66/sh−4,250$355,555→ 23,970 total
Footnotes (2)
- [F1]Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.
- [F2]Reflects the number of options outstanding after the transactions from this specific stock option grant.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001247681
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 8:22 PM ET
- Size
- 8.2 KB